We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

EDUC:NASDAQEducational Development Corporation Analysis

Data as of 2026-05-19 - not real-time

$1.50

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Educational Development Corporation trades at a **trailing P/E of 3.18**, dramatically below the publishing industry average of 17.23, and its DCF‑derived fair value of **$37.28** is more than 20× the current price of $1.495, indicating a deep valuation disconnect. The stock is also **underpriced on a price‑to‑book basis (0.28×)** and shows a **low beta of 0.61**, suggesting limited market volatility. Technically, the price sits above the 20‑day (1.444) and 200‑day (1.344) SMAs, the MACD line is bullish, but the **RSI is 76**, flagging an overbought condition, while volume trends are decreasing, hinting at waning short‑term momentum.
Fundamentally, the company faces a **revenue decline of 36.6%**, a **negative operating margin (-21.5%)**, and a high **debt‑to‑equity ratio (15.13)**, yet it generates positive operating cash flow and an unusually large free cash flow figure, providing a modest liquidity cushion. The lack of dividend and a modest market cap (~$12.7 M) raise liquidity concerns, but the low volatility, strong valuation upside, and potential for a turnaround support a **value‑oriented investment thesis**.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • RSI in overbought territory (76)
  • Decreasing volume trend
  • Price approaching resistance at $1.54

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Massive valuation gap (DCF $37.28 vs $1.495)
  • Low beta indicating limited downside volatility
  • Positive operating cash flow despite earnings loss

Long Term

> 3 years
Positive
Model confidence: 6/10

Key Factors

  • Sustained undervaluation on multiple multiples
  • Potential for turnaround in revenue and margins
  • Sector stability with low regulatory exposure

Key Metrics & Analysis

Financial Health

Revenue Growth-36.60%
Profit Margin16.11%
P/E Ratio3.2
ROE9.32%
ROA-5.60%
Debt/Equity15.13
P/B Ratio0.3
Op. Cash Flow$2.4M
Free Cash Flow$24.7M
Industry P/E17.2

Technical Analysis

TrendBullish
RSI76.5
Support$1.30
Resistance$1.54
MA 20$1.44
MA 50$1.37
MA 200$1.34
MACDBullish
VolumeDecreasing
Fear & Greed Index89.61

Valuation

Fair Value$37.28
GradeUndervalued
TypeValue

Risk Assessment

Beta0.61
Volatility18.57%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.